On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma Post author:Sam Post published:November 16, 2017 Post category:BioPharma Genentech scored two approvals from the FDA this week. Source: BioSpace You Might Also Like AbbVie and Voyager Therapeutics Launch $1.2 Billion+ Alzheimer’s Partnership February 19, 2018 Outgoing Novartis CEO Hunts for His Next Big Challenge January 24, 2018 Status Regarding Novo Nordisk A/S's Holding Of Its Own Shares (30 September 2017) October 1, 2017
